The Scientist

» drug development, evolution and immunology

Most Recent

image: America’s First Pooches

America’s First Pooches

By | January 27, 2015

Study of ancient dog DNA sheds light on early Americans’ relationships with their pets.

1 Comment

image: Interferon Discoverer Dies

Interferon Discoverer Dies

By | January 26, 2015

Jean Lindemann, the virologist who helped figure out that interferons were responsible for anti-viral responses, has passed away at age 90.

0 Comments

image: Fraction of SNPs Can Affect Fitness

Fraction of SNPs Can Affect Fitness

By | January 21, 2015

A point mutation analysis of the entire human genome finds that alterations to as many as 7.5 percent of nucleotides may have contributed to humans’ evolutionary split from chimpanzees.

1 Comment

image: Tracking Tuberculosis Over Time

Tracking Tuberculosis Over Time

By | January 19, 2015

Genomic analysis of a multidrug-resistant lineage pinpoints historical correlations with human events.

0 Comments

image: Inflammation Overdrive

Inflammation Overdrive

By | January 15, 2015

Experimental vaccines that specifically boost T helper cells lead to immunopathology and death in mice.

2 Comments

image: IOM Urges Data Sharing

IOM Urges Data Sharing

By | January 15, 2015

The Institute of Medicine says results from human clinical trials ought to be made available to independent researchers within 18 months.

0 Comments

image: Reassessing One Really Old Fish

Reassessing One Really Old Fish

By | January 13, 2015

New analysis of an ancient specimen prompts a rethink of fish forebears.

1 Comment

image: Shire Makes $5.2 Billion Buy

Shire Makes $5.2 Billion Buy

By | January 13, 2015

The Irish drugmaker moves on from its terminated sale to AbbVie to purchase New Jersey-based NPS Pharmaceuticals.

0 Comments

image: The Benefits of Being a “Bearded Lady”

The Benefits of Being a “Bearded Lady”

By | January 8, 2015

A study of female eastern fence lizards that bear a distinctly male trait yields tantalizing clues about the tradeoffs involved in blurring the lines of sexual dimorphism.

0 Comments

image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

1 Comment

Popular Now

  1. A Coral to Outlast Climate Change
  2. Science Celebrities: Where Are the Women?
  3. First In Vivo Human Genome Editing to Be Tested in New Clinical Trial
  4. Understanding Body Ownership and Agency
AAAS